Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 209

1.

Educational review: measurement of GFR in special populations.

Filler G, Lee M.

Pediatr Nephrol. 2017 Dec 7. doi: 10.1007/s00467-017-3852-8. [Epub ahead of print]

PMID:
29218435
2.

Is it time for a multi-specialty approach to cardio-renal dysfunction in children with cyanotic congenital heart disease?

Holt T, Filler G.

Pediatr Nephrol. 2017 Oct 2. doi: 10.1007/s00467-017-3805-2. [Epub ahead of print] No abstract available.

PMID:
28971263
3.

Strategies to reduce line infections in a small child with homozygous familial hypercholesterolaemia who cannot yet receive LDL apheresis.

Lee M, Barr J, Kribs S, Filler G.

BMJ Case Rep. 2017 Sep 1;2017. pii: bcr-2017-219538. doi: 10.1136/bcr-2017-219538.

PMID:
28866629
4.

We have to do more for former paediatric renal transplant recipients!

Filler G, Ferris M.

Transpl Int. 2017 Sep 2. doi: 10.1111/tri.13058. [Epub ahead of print]

PMID:
28865119
5.

When CRRT on ECMO Is Not Enough for Potassium Clearance: A Case Report.

Tijssen JA, Filler G.

Can J Kidney Health Dis. 2017 Aug 21;4:2054358117722559. doi: 10.1177/2054358117722559. eCollection 2017.

6.

A case control analysis investigating risk factors and outcomes for nephrocalcinosis and renal calculi in neonates.

Huynh M, Clark R, Li J, Filler G, Dave S.

J Pediatr Urol. 2017 Aug;13(4):356.e1-356.e5. doi: 10.1016/j.jpurol.2017.06.018. Epub 2017 Jul 27.

PMID:
28821388
7.

Generic immunosuppressants.

Medeiros M, Lumini J, Stern N, Castañeda-Hernández G, Filler G.

Pediatr Nephrol. 2017 Jul 21. doi: 10.1007/s00467-017-3735-z. [Epub ahead of print]

PMID:
28733752
8.

Deviations from the expected relationship between serum FGF23 and other markers in children with CKD: a cross-sectional study.

Liu D, Alvarez-Elías AC, Wile B, Belostotsky V, Filler G.

BMC Nephrol. 2017 Jun 28;18(1):204. doi: 10.1186/s12882-017-0623-5.

9.

A cross-sectional study measuring vanadium and chromium levels in paediatric patients with CKD.

Filler G, Kobrzynski M, Sidhu HK, Belostotsky V, Huang SS, McIntyre C, Yang L.

BMJ Open. 2017 Jun 6;7(5):e014821. doi: 10.1136/bmjopen-2016-014821.

10.

Seizures Related to Hypomagnesemia: A Case Series and Review of the Literature.

Chen BB, Prasad C, Kobrzynski M, Campbell C, Filler G.

Child Neurol Open. 2016 Oct 27;3:2329048X16674834. doi: 10.1177/2329048X16674834. eCollection 2016 Jan-Dec.

11.

High prevalence of elevated molybdenum levels in pediatric CKD patients. A cross-sectional and longitudinal study
.

Filler G, Belostotsky V, Kobrzynski M, Huang SS, Yang L.

Clin Nephrol. 2017 Aug;88(8):79-85. doi: 10.5414/CN109015.

PMID:
28502322
12.

A Retrospective Study on Mycophenolic Acid Drug Interactions: Effect of Prednisone, Sirolimus, and Tacrolimus With MPA.

Alvarez-Elías AC, Yoo EC, Todorova EK, Singh RN, Filler G.

Ther Drug Monit. 2017 Jun;39(3):220-228. doi: 10.1097/FTD.0000000000000403.

PMID:
28437284
13.

Improving long-term outcomes after pediatric renal transplantation by addressing dyslipidemia.

Filler G, Medeiros M.

Pediatr Transplant. 2017 May;21(3). doi: 10.1111/petr.12880. No abstract available.

PMID:
28370889
14.

Barriers to the Implementation of Lipoprotein Apheresis in Canada.

Filler G, Lee M, Hegele RA.

Can J Cardiol. 2017 Mar;33(3):409-411. doi: 10.1016/j.cjca.2017.01.008. Epub 2017 Jan 21. Review.

PMID:
28232020
15.

Spot urine protein to creatinine ratio.

Filler G, Huang SS.

Pediatr Nephrol. 2017 Jun;32(6):917-919. doi: 10.1007/s00467-017-3605-8. Epub 2017 Feb 14.

PMID:
28197886
16.

Idiosyncratic drug reactions and membranous glomerulopathy.

Kirpalani A, Rieder MJ, Bax KC, Filler G.

BMJ Case Rep. 2017 Jan 30;2017. pii: bcr2016218496. doi: 10.1136/bcr-2016-218496.

PMID:
28137906
17.

Improving the translation of novel biomarkers to clinical practice: The story of cystatin C implementation in Canada: A professional practice column.

Ismail OZ, Bhayana V, Kadour M, Lepage N, Gowrishankar M, Filler G.

Clin Biochem. 2017 May;50(7-8):380-384. doi: 10.1016/j.clinbiochem.2017.01.005. Epub 2017 Jan 11. No abstract available.

PMID:
28088453
18.

Is Fibroblast Growth Factor 23 the New Biomarker for Cardiovascular Mortality in Chronic Kidney Disease Patients?

Filler G, McIntyre C.

Am J Nephrol. 2017;45(2):146-148. doi: 10.1159/000454961. Epub 2016 Dec 23. No abstract available.

19.

Is a reduction in cystometric bladder capacity in anuric infants post-renal transplant really no big deal?

Filler G, Dave S.

Pediatr Transplant. 2016 Dec;20(8):1016-1017. doi: 10.1111/petr.12806. No abstract available.

PMID:
27882689
20.

Can the new CKD-EPI BTP-B2M formula be applied in children?

Filler G, Alvarez-Elías AC, Westreich KD, Huang SS, Lindsay RM.

Pediatr Nephrol. 2016 Dec;31(12):2175-2177. Epub 2016 Sep 19.

PMID:
27647182

Supplemental Content

Loading ...
Support Center